A number of global economic factors acting in concert are expected to result in a continued rise in carve-out transactions, as corporations of all sizes and across all industries are seeking to divest subsidiaries, assets, or teams that do not align with their corporate strategy.
The team of transaction advisory specialists within Marsh’s Private Equity and Mergers & Acquisitions (PEMA) Practice is well positioned to help you navigate the insurance challenges that can arise in such deals. We can help you identify the risks associated with the transaction and help you address the challenges that you may face through the process.
Carve-out transactions can carry several risks that should be considered before the sale is completed. These can include:
In a share purchase, the buyer will usually be acquiring the target with all of its liabilities. However, a new standalone insurance program incepted at completion for the target will typically not cover pre-completion liabilities by default.
Some cover for these liabilities may be available through conditional ongoing access to the seller’s insurance program. However, such access is subject to negotiation with the seller and careful SPA drafting. Additionally, buyers should be aware that the seller’s policy deductibles/excesses would apply to any claim under the seller’s program; these could be significantly higher than the newly standalone target can afford.
The target may also seek to cover some pre-completion liabilities via its new standalone insurance program. However, when available, this coverage is likely to be limited. Further, insurers will often require detailed target-specific information that may not have been recorded by the seller.
In most carve-outs, the target requires an entirely new insurance program at completion, since it typically will no longer benefit from insurance previously provided by the seller. This new program may need to be very different from the seller’s previous arrangements, given the target’s distinct size and risk profile.
Additionally, if the procurement of insurance was previously handled centrally by the seller, the target’s management team may have little or no prior experience with the processes. Further, while some of the information required to secure insurance quotations may be available from the seller, some may not and as such may need to be built up from scratch. A narrow window of time between signing and completion may make it more challenging to have a robust insurance program ready for the target by Day 1.
Marsh McLennan is one of the largest advisors in the private equity space; we work with more than 2,000 private equity funds, including global top 30 funds.
What we do for private equity clients
Commercial, operational, technical and pricing due diligence; building post-close operational value creation, revenue uplift strategies and M&A plans.
How we do it
Private Capital team with 300+ partners and aligned consultants across hubs in the Americas, Europe, and Asia-Pacific.
What we do for private equity clients
HR due diligence and Day 1 readiness across leadership, talent, renumeration, culture, and HR systems; optimizing talent attraction, retention, and the employee experience at portfolio companies.
How we do it
Global Private Equity Advisory Practice with 180+ HR M&A specialists. Mercer Alternatives also manages US$24 billion in private markets, with 220+ professionals.
What we do for private equity clients
Advising private equity funds on managing transactional risks as well as risk and insurance diligence; optimizing approaches to risk management and insurance for portfolio companies.
How we do it
Dedicated Private Equity and M&A (PEMA) practice with 400+ deal risk experts across 30 countries inclusive of 100+ transactional risk brokers.